Leading specialty pharmaceuticals company focusing on therapeutics to treat allergic & respiratory diseases and pain
MedPointe was a fast-growing pharmaceutical company focusing on developing and commercializing a broad portfolio of therapeutics. The company’s products were focused on the Allergy / Respiratory and Pain therapeutic areas, and included leading brands such as Astelin for allergic and non-allergic rhinitis and Optivar for allergic conjunctivitis. In 2006, MedPointe generated $252M in sales (>20% annual growth), and Meda purchased MedPointe in 2007 to expand operations into the US.
